Avante Provides Debt and Equity to Support Dexmet Deal
March 11, 2013
Avante Mezzanine Partners has announced that it provided subordinated debt and an equity co-investment to support Sverica's recent acquisition of Dexmet. Dexmet develops and manufactures expanded metals and polymeric materials, with product applications like lightning protection for aircraft, high-performance batteries and other niche applications. Based in Los Angeles and Boston, Avante invests subordinated debt and minority equity capital of $5 million to $20 million in companies with $3 million $15 million of EBITDA.